SBTi Registry
Explore 1 matching companies with public, verified Science Based Targets commitments.
Data sourced from the Science Based Targets initiative (SBTi).
Show
20
per page| Sector | Region | Near-Term Status | Size | ||||
|---|---|---|---|---|---|---|---|
| Porton Pharma Solutions Ltd. | Pharmaceuticals, Biotechnology and Life Sciences | Asia | Targets set | Large | - | Mar 20, 2025 | |
Near-Term Status Targets set Near-Term Classification 1.5°C Near-Term Target Year 2030 Long-Term Status - Net-Zero Status - Net-Zero Year - Sector Pharmaceuticals, Biotechnology and Life Sciences Region Asia Organization Type Corporate Location China Company Size Large Target Statement Porton Pharma Solutions Ltd. commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2023 base year. Porton Pharma Solutions Ltd. also commits to reduce absolute scope 3 GHG emissions covering purchased goods and services, fuel and energy related activities, ups… Stakeholders No stakeholders identified yet. | |||||||
Show
20
per pageTurn Commitments Into Impact
Thousands of companies have set public Scope 3 emissions-reduction targetsthrough SBTi, but few have the tools to deliver on them. Carbon3 gives you the infrastructure to plan, track, and execute the supply-chain decarbonization work behind your commitment, turning a public pledge into measurable progress. See how it works.